03.06.26 -- Rethinking Product Development Through Lipid-Based Formulations

Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

Manual quality processes can’t keep up with today’s compliance demands. Discover why an intelligent, digital QMS is essential for reducing risk, improving efficiency, and building a strong foundation.

Drug shortages have increased the burden on compounding pharmacies. Robotics and automation can streamline processes, improve accuracy, and ensure quality to address these challenges.

Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.

To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

Paper-based processes slow down life sciences manufacturing and introduce compliance risks. Examine how digital procedures and electronic logbooks can boost accuracy, speed, and traceability.

Read how scalable lipid nanoparticle (LNP) technology is revolutionizing mRNA-based therapies and shaping the future of treatment innovation.

Manufacturers are using continuous processing, analytics, and enzyme‑driven chemistry to cut waste, accelerate development, and enable safer, adaptable workflows amid rising sustainability demands.

As capacity expands and capabilities mature, CDMOs with global scale and advanced injectable expertise are becoming critical partners for bringing complex sterile drug products to market.

Iwan Bertholjotti, director of commercial bioconjugate development, and Dr. Bernhard Stump, head of bioconjugate development, discuss complexity and uncertainty in the bioconjugates market.

Find out how a Liver-Chip revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.

Gain insight into the advantages offered by an orally dissolving tablet platform relating to large molecule storage, aggregation, and, in some cases, protease activity.

Harness real-time data and advanced analytics to optimize pharmaceutical manufacturing. Improve efficiency, ensure compliance, and reduce environmental impact through seamless digital integration.